HOME >> BIOLOGY >> NEWS
Pioneering AIDS researcher to speak at UH

In his lecture AIDS: From Vaccine Research to Public Health Ho will speak about strides in research that have come about due to the AIDS epidemic in China, where estimates expect the total case load to reach 10 million infected with HIV by 2010.

Ho will talk about a DNA vaccine that has already reached phase-I human trial, as well as discuss two more vaccines under development. These vaccines under development are based on a viral strain common in Chinas southwest region. The China AIDS Initiative, a consortium of Chinese and American organizations that have come together to combine forces in advocacy, public education, testing and prevention work, and antiretroviral therapy, will also be discussed.

It is most gratifying to have our work progress from the discovery of new knowledge to the application of old knowledge, Ho said. To go from basic research to clinical applications to public health in the land of my heritage is especially rewarding.

Ho is the founding scientific director and CEO of the Aaron Diamond AIDS Research Center, a world-renowned biomedical research institute, the Irene Diamond Professor at The Rockefeller University and a Committee of 100 (C-100) member.

Brought to UH by C-100, a national organization composed of more than 100 of the most influential Chinese Americans in the United States, Hos lecture is also sponsored by UHs Texas Center for Superconductivity and Advanced Materials, the Office of Houston City Council Member Gordon Quan and Leadership Education for Asian Pacifics (LEAP). The event is being held in conjunction with a daylong Asian-American professional development workshop co-hosted by LEAP and C-100 at the Houston Community College administration building.

Holding six honorary doctorates, a member of the Institute of Medicine of the National Academy of Arts and Sciences, Time magazines 1996 Man of the Year and a 2001 Presidential Medal recipient, Ho has been actively engage
'"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
14-Sep-2004


Page: 1 2

Related biology news :

1. Pioneering discoveries, pursuing new knowledge, fostering partnerships
2. Pioneering flu researcher wins major Imperial scientific award
3. Pioneering study compares 13 vertebrate genomes
4. UFS Mcknight Brain Institute researchers: Pioneering spinal cord procedure appears safe
5. Pioneering experiments testing effects of greenhouse gases on crops
6. Pioneering evolutionist Ledyard Stebbins dies at age 94
7. Pioneering Research Could Lead To Treatment
8. Belgian researchers explore revolutionary approach to angiogenesis
9. Award winning researchers reveal potential new role for Glivec
10. University of Alberta researcher looks for clues to mysterious disease
11. $7.5 Million grant to Yale researchers for role of viruses in cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: